Recombinant human parathyroid hormone (PTH 1-34) and low-intensity pulsed ultrasound have contrasting additive effects during fracture healing

被引:56
|
作者
Warden, Stuart J. [1 ,2 ]
Komatsu, David B. [1 ,3 ]
Rydberg, Johanna [1 ]
Bond, Julie L. [1 ]
Hassett, Sean M. [1 ]
机构
[1] Indiana Univ, Dept Phys Therapy, Sch Hlth & Rehabil Sci, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA
[3] InMot Musculoskeletal Inst, Biolog & Biomat Lab, Memphis, TN USA
关键词
Animal model; Orthopedics; Physical therapy; Teriparatide; Ultrasound therapy; AGGRECAN GENE-EXPRESSION; HUMAN PARATHYROID-HORMONE-(1-34); THERAPEUTIC ULTRASOUND; BONE-FORMATION; CORTICAL BONE; IN-VIVO; TRABECULAR BONE; AKT PATHWAY; REPAIR; MODEL;
D O I
10.1016/j.bone.2008.11.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fracture healing is thought to be naturally optimized; however, recent evidence indicates that it may be manipulated to occur at a faster rate. This has implications for the duration of morbidity associated with bone injuries. Two interventions found to accelerate fracture healing processes are recombinant human parathyroid hormone [1-34] (PTH) and low-intensity pulsed ultrasound (LIPUS). This study aimed to investigate the individual and combined effects of PTH and LIPUS on fracture healing. Bilateral midshaft femur fractures were created in Sprague-Dawley rats, and the animals treated 7 days/week with PTH (10 mu g/kg) or a vehicle solution. Each animal also had one fracture treated for 20 min/day with active-LIPUS (spatial-averaged, temporal-averaged intensity I(SATA)]= 100 mW/cm(2)) and the contralateral fracture treated with inactive-LIPUS (placebo). Femurs were harvested 35 days following injury to permit micro-computed tomography, mechanical property and histological assessments of the fracture calluses. There were no interactions between PTH and LIPUS indicating that their effects were additive rather than synergistic. These additive effects were contrasting with LIPUS primarily increasing total callus volume (TV) without influencing bone mineral content (BMC), and PTH having the opposite effect of increasing BMC without influencing TV. As a consequence of the effect of LIPUS on TV but not BMC, it decreased volumetric bone mineral density (vBMD) resulting in a less mature callus. The decreased maturity and persistence of cartilage at the fracture site when harvested offset any beneficial mechanical effects of the increased callus size with LIPUS. In contrast, the effect of PTH on callus BMC but not TV resulted in increased callus vBMD and a more mature callus. This resulted in PTH increasing fracture site mechanical strength and stiffness. These data suggest that PTH may have utility in the treatment of acute bone fractures, whereas LIPUS at an I(SATA) Of 100 mW/cm(2) does not appear to be indicated in the management of closed, diaphyseal fractures. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:485 / 494
页数:10
相关论文
共 50 条
  • [31] Effect of Exogenous Intermittent Recombinant Human PTH 1-34 Administration and Chronic Endogenous Parathyroid Hormone Excess on Glucose Homeostasis and Insulin Sensitivity
    Anastasilakis, A. D.
    Efstathiadou, Z.
    Plevraki, E.
    Koukoulis, G. N.
    Slavakis, A.
    Kita, M.
    Avramidis, A.
    [J]. HORMONE AND METABOLIC RESEARCH, 2008, 40 (10) : 702 - 707
  • [32] Anabolic effects of recombinant human parathyroid hormone (1-84) and synthetic human parathyroid hormone (1-34) on the mandibles of osteopenic ovariectomized rats with maxillary molar extraction
    Kawane, T
    Takahashi, S
    Saitoh, H
    Okamoto, H
    Kubodera, N
    Horiuchi, N
    [J]. HORMONE AND METABOLIC RESEARCH, 2002, 34 (06) : 293 - 302
  • [33] Effects of parathyroid hormone 1-34 on osteogenic and chondrogenic differentiation of human fracture haematoma-derived cells in vitro
    Dogaki, Yoshihiro
    Lee, Sang Yang
    Niikura, Takahiro
    Koga, Takaaki
    Okumachi, Etsuko
    Nishida, Kotaro
    Kuroda, Ryosuke
    Kurosaka, Masahiro
    [J]. JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2016, 10 (10) : E365 - E371
  • [34] Low-intensity pulsed ultrasound increased blood vessel size during fracture healing in patients with a delayed-union of the osteotomized fibula
    Korstjens, Clara M.
    Rutten, Sjoerd
    Nolte, Peter A.
    van Duin, Marion A.
    Klein-Nulend, Jenneke
    [J]. HISTOLOGY AND HISTOPATHOLOGY, 2018, 33 (07) : 737 - 746
  • [35] The reduced risk of new vertebral fracture persists for up to 18 months following treatment of postmenopausal osteoporosis with recombinant human parathyroid hormone (1-34).
    Lindsay, R
    Scheele, WH
    Clancy, AD
    Mitlak, BH
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S379 - S379
  • [36] Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora
    Komatsubara, S
    Mori, S
    Mashiba, T
    Nonaka, K
    Seki, A
    Akiyama, T
    Miyamoto, K
    Cao, YP
    Manabe, T
    Norimatsu, H
    [J]. BONE, 2005, 36 (04) : 678 - 687
  • [37] Recombinant human parathyroid hormone (1-34) therapy reduces the incidence of moderate/severe vertebral fractures in men with low bone density.
    Orwoll, E
    Scheele, WH
    Clancy, AD
    Adami, S
    Syversen, U
    Diez-Perez, A
    Myers, SL
    Mitlak, BH
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S162 - S162
  • [38] Effects of LY333334 [recombinant human parathyroid hormone (1-34)] and alendronate sodium on markers of bone metabolism in postmenopausal women with osteoporosis.
    Body, JJ
    Gaich, GA
    Scheele, WH
    Kulkarni, PM
    Hodsman, AB
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S530 - S530
  • [39] Incident vertebral fractures during an 18-month observation period following discontinuation of LY333334 [recombinant human parathyroid hormone (1-34), rhPTH(1-34)] use in postmenopausal women with osteoporosis.
    Lindsay, R
    Scheele, WH
    Clancy, AD
    Mitlak, BH
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S162 - S162
  • [40] Assessment of effects of LY333334 [recombinant human parathyroid hormone (1-34)] on cortical bone using digital X-ray radiogrammetry.
    Hyldstrup, L
    Jorgensen, JT
    Gaich, G
    [J]. BONE, 2001, 28 (05) : S97 - S98